Skip to Main Content

Paper Details

Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers.
J Immunother Cancer
32
2021
Patients, advanced rare cancer, advanced rare cancers, histogram, patients, pembrolizumab, tumor
Author NameAffiliation
Rivka R ColenUniversity of Pittsburgh
Rivka R ColenHillman Cancer Center, University of Pittsburgh Medical Center
Spyridon BakasUniversity of Pennsylvania Perelman School of Medicine
Christine B PetersonThe University of Texas MD Anderson Cancer Center
  • 1 - 4

Datasets

Release 1.2